<?xml version='1.0' encoding='utf-8'?>
<document id="28373111"><sentence text="Pretreatment With Rifampicin and Tyrosine Kinase Inhibitor Dasatinib Potentiates the Inhibitory Effects Toward OATP1B1- and OATP1B3-Mediated Transport."><entity charOffset="18-28" id="DDI-PubMed.28373111.s1.e0" text="Rifampicin" /><entity charOffset="33-41" id="DDI-PubMed.28373111.s1.e1" text="Tyrosine" /><pair ddi="false" e1="DDI-PubMed.28373111.s1.e0" e2="DDI-PubMed.28373111.s1.e0" /><pair ddi="false" e1="DDI-PubMed.28373111.s1.e0" e2="DDI-PubMed.28373111.s1.e1" /></sentence><sentence text="Present studies determined the effects of pretreatment with rifampicin, an organic anion-transporting polypeptide (OATP) inhibitor, and the tyrosine kinase inhibitor dasatinib on OATP1B1- and OATP1B3-mediated transport, and evaluated the OATP-mediated drug-drug interaction potential of dasatinib using the static R-value and dynamic physiologically based pharmacokinetic models"><entity charOffset="60-70" id="DDI-PubMed.28373111.s2.e0" text="rifampicin" /><entity charOffset="140-148" id="DDI-PubMed.28373111.s2.e1" text="tyrosine" /><entity charOffset="166-175" id="DDI-PubMed.28373111.s2.e2" text="dasatinib" /><entity charOffset="287-296" id="DDI-PubMed.28373111.s2.e3" text="dasatinib" /><pair ddi="false" e1="DDI-PubMed.28373111.s2.e0" e2="DDI-PubMed.28373111.s2.e0" /><pair ddi="false" e1="DDI-PubMed.28373111.s2.e0" e2="DDI-PubMed.28373111.s2.e1" /><pair ddi="false" e1="DDI-PubMed.28373111.s2.e0" e2="DDI-PubMed.28373111.s2.e2" /><pair ddi="false" e1="DDI-PubMed.28373111.s2.e0" e2="DDI-PubMed.28373111.s2.e3" /><pair ddi="false" e1="DDI-PubMed.28373111.s2.e1" e2="DDI-PubMed.28373111.s2.e1" /><pair ddi="false" e1="DDI-PubMed.28373111.s2.e1" e2="DDI-PubMed.28373111.s2.e2" /><pair ddi="false" e1="DDI-PubMed.28373111.s2.e1" e2="DDI-PubMed.28373111.s2.e3" /><pair ddi="false" e1="DDI-PubMed.28373111.s2.e2" e2="DDI-PubMed.28373111.s2.e2" /><pair ddi="false" e1="DDI-PubMed.28373111.s2.e2" e2="DDI-PubMed.28373111.s2.e3" /></sentence><sentence text=" Rifampicin and dasatinib pretreatment significantly decreased OATP1B1- and OATP1B3-mediated transport"><entity charOffset="1-11" id="DDI-PubMed.28373111.s3.e0" text="Rifampicin" /><entity charOffset="16-25" id="DDI-PubMed.28373111.s3.e1" text="dasatinib" /><pair ddi="false" e1="DDI-PubMed.28373111.s3.e0" e2="DDI-PubMed.28373111.s3.e0" /><pair ddi="false" e1="DDI-PubMed.28373111.s3.e0" e2="DDI-PubMed.28373111.s3.e1" /></sentence><sentence text=" Rifampicin pretreatment also significantly decreased [3H]-pitavastatin and [3H]-CCK-8 accumulation in human sandwich-cultured hepatocytes"><entity charOffset="1-11" id="DDI-PubMed.28373111.s4.e0" text="Rifampicin" /><entity charOffset="54-71" id="DDI-PubMed.28373111.s4.e1" text="[3H]-pitavastatin" /><entity charOffset="76-86" id="DDI-PubMed.28373111.s4.e2" text="[3H]-CCK-8" /><pair ddi="false" e1="DDI-PubMed.28373111.s4.e0" e2="DDI-PubMed.28373111.s4.e0" /><pair ddi="false" e1="DDI-PubMed.28373111.s4.e0" e2="DDI-PubMed.28373111.s4.e1" /><pair ddi="false" e1="DDI-PubMed.28373111.s4.e0" e2="DDI-PubMed.28373111.s4.e2" /><pair ddi="false" e1="DDI-PubMed.28373111.s4.e1" e2="DDI-PubMed.28373111.s4.e1" /><pair ddi="false" e1="DDI-PubMed.28373111.s4.e1" e2="DDI-PubMed.28373111.s4.e2" /></sentence><sentence text=" Present studies revealed that estrone-3-sulfate is a less-sensitive OATP1B1 substrate than estradiol-17β-glucuronide in assessing rifampicin pretreatment effects"><entity charOffset="31-48" id="DDI-PubMed.28373111.s5.e0" text="estrone-3-sulfate" /><entity charOffset="92-117" id="DDI-PubMed.28373111.s5.e1" text="estradiol-17β-glucuronide" /><entity charOffset="131-141" id="DDI-PubMed.28373111.s5.e2" text="rifampicin" /><pair ddi="false" e1="DDI-PubMed.28373111.s5.e0" e2="DDI-PubMed.28373111.s5.e0" /><pair ddi="false" e1="DDI-PubMed.28373111.s5.e0" e2="DDI-PubMed.28373111.s5.e1" /><pair ddi="false" e1="DDI-PubMed.28373111.s5.e0" e2="DDI-PubMed.28373111.s5.e2" /><pair ddi="false" e1="DDI-PubMed.28373111.s5.e1" e2="DDI-PubMed.28373111.s5.e1" /><pair ddi="false" e1="DDI-PubMed.28373111.s5.e1" e2="DDI-PubMed.28373111.s5.e2" /></sentence><sentence text=" Pretreatment with rifampicin and dasatinib reduced the inhibition constant (Ki) values against OATP1B1 by 3 and 2"><entity charOffset="19-29" id="DDI-PubMed.28373111.s6.e0" text="rifampicin" /><entity charOffset="34-43" id="DDI-PubMed.28373111.s6.e1" text="dasatinib" /><pair ddi="false" e1="DDI-PubMed.28373111.s6.e0" e2="DDI-PubMed.28373111.s6.e0" /><pair ddi="false" e1="DDI-PubMed.28373111.s6.e0" e2="DDI-PubMed.28373111.s6.e1" /></sentence><sentence text="1 fold and against OATP1B3 by 2" /><sentence text="4 and 2" /><sentence text="1 fold, respectively" /><sentence text=" The in vitro rifampicin Ki values after preincubation are comparable to the estimated in vivo Ki reported previously" /><sentence text=" Models predict that dasatinib has a low potential to cause OATP1B1- and OATP1B3-mediated drug-drug interactions"><entity charOffset="21-30" id="DDI-PubMed.28373111.s11.e0" text="dasatinib" /></sentence><sentence text=" Time-lapse confocal microscopy demonstrated that rifampicin and dasatinib pretreatment did not affect plasma membrane localization of green-fluorescent protein-tagged OATP1B1 (GFP-OATP1B1) and GFP-OATP1B3 in human embryonic kidney 293 stable cell lines"><entity charOffset="50-60" id="DDI-PubMed.28373111.s12.e0" text="rifampicin" /><entity charOffset="65-74" id="DDI-PubMed.28373111.s12.e1" text="dasatinib" /><pair ddi="false" e1="DDI-PubMed.28373111.s12.e0" e2="DDI-PubMed.28373111.s12.e0" /><pair ddi="false" e1="DDI-PubMed.28373111.s12.e0" e2="DDI-PubMed.28373111.s12.e1" /></sentence><sentence text=" In summary, we report novel findings that pretreatment with rifampicin and dasatinib potentiates the inhibitory effects toward OATP1B1 and OATP1B3 without affecting plasma membrane levels of the transporters"><entity charOffset="61-71" id="DDI-PubMed.28373111.s13.e0" text="rifampicin" /><entity charOffset="76-85" id="DDI-PubMed.28373111.s13.e1" text="dasatinib" /><pair ddi="false" e1="DDI-PubMed.28373111.s13.e0" e2="DDI-PubMed.28373111.s13.e0" /><pair ddi="false" e1="DDI-PubMed.28373111.s13.e0" e2="DDI-PubMed.28373111.s13.e1" /></sentence><sentence text="" /></document>